Posted on 2/1/21
Invest in Others Charitable Foundation Elects Three New Board Members
The Invest in Others Charitable Foundation announces the election of three new members to its Board of Directors, including: Stacy Bernstein, Head of Financial Intermediaries and . . .
Posted on 2/1/21
MOMA Therapeutics Appoints Asit Parikh, M.D., Ph.D. as Chief Executive Officer
MOMA Therapeutics, a biopharmaceutical company discovering the next generation of precision medicines by targeting molecular machines that underlie human disease
Posted on 1/30/21
Sensei Biotherapeutics Appoints Deneen Vojta, M.D. to its Board of Directors
Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company focused on the discovery and development of next
Posted on 1/29/21
PureTech Appoints Bharatt Chowrira to Board
PureTech Health plc (LSE: PRTC, Nasdaq: PRTC), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases
Posted on 1/29/21
Ellington Financial Appoints Ronald Simon and Stephen Dannhauser to Board
Ellington Financial Inc. (NYSE: EFC) announced that Dr. Ronald I. Simon, an Independent Director of the Company since 2007
Posted on 1/29/21
ApiJect Systems, Corp., Announces Company's New Leadership Advisory Board
ApiJect Systems, Corp, a public benefit corporation based in Stamford, CT., announced today the creation of its new Leadership Advisory Board,
Posted on 1/28/21
PlateletBio Appoints Dr. Steven Altschuler as Chairman of its Board of Directors
PlateletBio, a pioneering biotechnology company developing next-generation allogeneic cell therapies for treatment of human diseases, has named Steven M. Altschuler, M.D.
Posted on 1/27/21
Goric Appoints Laura Guscott as CEO
Goric Marketing Group, the importer and distributor of fine European playground equipment in North America, has named Laura Guscott its new President and CEO. Guscott assumes . . .
Posted on 1/27/21
HoldCo Nominates Five Candidates for Boston Private Financial Holdings Board
NEW YORK--(BUSINESS WIRE)--HoldCo Asset Management, LP and its managed funds, which own 4,049,816 shares of common stock of Boston Private Financial Holdings, Inc. (NASDAQ: BPFH), representing . . .
Posted on 1/27/21
IM Therapeutics Appoints Jonathan Rigby to Board
ImmunoMolecular Therapeutics, Inc., a clinical stage company developing personalized therapies for autoimmune disease, announced today that Jonathan Rigby
Posted on 1/26/21
Jim Mollica Joins SquadLocker Board of Directors
SquadLocker, a leading provider of online tools and services for teams and organizations to manage custom apparel and equipment purchasing, announced that Jim Mollica, digital marketing . . .
Posted on 1/26/21
Lumeon Appoints Tom Zajac to Board
Lumeon, the leader in care journey orchestration, today announced the appointment of Tom Zajac to the Lumeon Board of Directors, effective December 20, 2020.
Posted on 1/26/21
Berkshire Hills Bancorp Names Nitin Mhatre CEO
Berkshire Hills Bancorp, Inc. (NYSE: BHLB) (Company), the parent company of Berkshire Bank, announced today
Posted on 1/26/21
Butterfly Network and Longview Acquisition Corp. Announce Todd Fruchterman to Become CEO of the Combined Company
Butterfly Network, Inc., an innovative digital health company that is working to enable universal access to superior
Posted on 1/25/21
Biostage Strengthens Appoints Herman Sanchez to Board
Biostage, Inc. (OTCQB: BSTG), a bioengineering company developing next-generation esophageal implants, today announced that it appointed Herman Sanchez as an independent director to its Board of . . .
Posted on 1/25/21
Alex Spiro Appointed Chairman of the Board of Directors of GlassBridge Enterprises
GlassBridge Enterprises, Inc. (OTC: GLAE) is pleased to announce that attorney Alex Spiro has been elected Chairman of the Board of Directors of the Company.
Posted on 1/25/21
Faze Medicines Appoints Philip Vickers as Chief Executive Officer
Faze Medicines, a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced that it has appointed Philip Vickers, Ph.D.,
Posted on 1/25/21
KSQ Therapeutics Appoints Qasim Rizvi as Chief Executive Officer
KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics discovery platform to systematically screen the whole genome to identify optimal gene targets for oncology and autoimmune . . .
Posted on 1/25/21
Cyclerion Therapeutics Appoints Clinical and Scientific Advisory Boards
CAMBRIDGE, Mass., Jan. 25, 2021 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), a clinical-stage biopharmaceutical company on a mission to develop treatments that restore cognitive . . .
Posted on 1/22/21
Away Appoints Jen Rubio as Interim CEO
Global lifestyle brand Away today announced its Chief Executive Officer Stuart Haselden will leave the company in February to pursue another opportunity.
Posted on 1/22/21
Independent Bank Corp. and Rockland Trust Company Appoint Warren Fields and James O’Shanna Morton to Board
Independent Bank Corp. (Nasdaq Global Select Market: INDB), parent of Rockland Trust Company
Posted on 1/21/21
PTC Appoints Mark Benjamin to Its Board of Directors
PTC (NASDAQ: PTC) has appointed Mark D. Benjamin to its Board of Directors effective February 10, 2021.
Posted on 1/21/21
Keurig Dr Pepper Appoints Juliette Hickman to Board
Keurig Dr Pepper Inc. (NASDAQ: KDP) announced today that Juliette Hickman has been appointed a director of the KDP board, effective January 18, 2021. Juliette is . . .
Posted on 1/21/21
Cerevel Therapeutics Appoints Deval Patrick and Deborah Baron to its Board of Directors
CAMBRIDGE, Mass., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, announced today . . .
Posted on 1/21/21
Black Diamond Therapeutics Appoints Dr. Kapil Dhingra to Board of Directors
Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic
Boston
